April 16, 2019 Healthcare, Top Market News 0 Comments Analysts Offer Insights on Healthcare Companies: Mesoblast Ltd (NASDAQ: MESO) and Albireo Pharma Inc (NASDAQ: ALBO)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mesoblast Ltd (MESO – Research Report) and Albireo Pharma Inc (ALBO – Research Report) with bullish sentiments.Mesoblast Ltd (MESO)In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Mesoblast Ltd, with a price target of $16. The company’s shares opened today at $5.75.
April 16, 2019 Healthcare, Top Market News 0 Comments Analysts...
-
- There are more pages in this discussion • 17,401 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.010(1.06%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 95.0¢ | 92.0¢ | $658.0K | 705.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 53731 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 92187 | 19 |
View Market Depth
| Last trade - 11.09am 03/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |